The Ad5-EBOV vaccine developed in China relies on the recombinant replication-defective human adenovirus type-5 vector to induce immune responses and provide protection against the Ebola virus.

Data show that GeneJammer dramatically increases the number of cells transduced. For more details, take a look at C.M. Fouletier-Dilling et al. 2005, Human Gene Therapy, 16:1287–1297. Adenovirus 5 is ...